雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Review of clinical trials of type B monoamine oxidase inhibitor and catechol-O-methyltransferase inhibitors; from the standpoint of Evidence Based Medicine. Mitsutoshi YAMAMOTO 1 1Department of Neurology, Kagawa Prefectural Central Hospltal Keyword: selegiline , entacapone , tolcapone , Parkinson's disease , double-blind trial , EBM pp.616-627
Published Date 2000/8/10
DOI https://doi.org/10.11477/mf.1431901176
  • Abstract
  • Look Inside

Clinical trials of selegiline, a type B monoamine oxidase (MAOB) inhibitor and catechol-O-methyltransferase (COMT) inhibitors are reviewed from the standpoint of Evidence Based Medicine. They are adjunctive drugs in the treatment of Parkinson's disease. This review mainly aims to analysis class 1 level clinical trials according to Evidence Based Medicine. Selegiline (deprenyl) has a long history of using in treating Parkinson's disease and is the only MAOB inhibitor in the world.


Copyright © 2000, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1243 印刷版ISSN 0001-8724 医学書院

関連文献

もっと見る

文献を共有